Literature DB >> 16596382

Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma.

Jun Nishio1, John D Gentry, James R Neff, Marilu Nelson, Wayne Daniels, Deborah Perry, Zoran Gatalica, Julia A Bridge.   

Abstract

Small cell osteosarcoma is a rare bone tumor of high-grade malignancy that most often arises in the metaphysis of long bones in the second decade of life. Cytogenetic and molecular genetic findings in small cell osteosarcoma are poorly defined. Conventional cytogenetic analysis of a small cell osteosarcoma arising in the proximal tibia of a 9-year-old male revealed a diploid chromosomal complement with complex structural rearrangements involving chromosomes 6, 16, and 17. Immunohistochemical assessment of p53 protein expression revealed nuclear p53 immunoreactivity in approximately 15% of the neoplastic cells. Subsequent fluorescence in situ hybridization (FISH) analyses confirmed loss of the p53 gene locus on the derivative chromosome 17 homolog and were negative for amplification of the MDM2, CDK4, c-MYC, HER-2/neu, CCND1, and COPS3 gene loci. To the best of our knowledge, this represents the first demonstration of monoallelic deletion of p53 in small cell osteosarcoma, suggesting that p53 alterations may play an important role in the development of small cell osteosarcoma as well as conventional osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596382     DOI: 10.1007/s00428-006-0181-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

2.  Small cell osteosarcoma of bone. Review of 72 cases.

Authors:  H Nakajima; F H Sim; J R Bond; K K Unni
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

3.  Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study.

Authors:  R S Bridge; J A Bridge; J R Neff; S Naumann; P Althof; L A Bruch
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

4.  The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.

Authors:  Beverly W Baron; John Anastasi; Michael J Thirman; Yoichi Furukawa; Scott Fears; David C Kim; Federico Simone; Mark Birkenbach; Anthony Montag; Annamma Sadhu; Nancy Zeleznik-Le; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

5.  Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.

Authors:  T Tsuchiya; K Sekine; S Hinohara; T Namiki; T Nobori; Y Kaneko
Journal:  Cancer Genet Cytogenet       Date:  2000-07-15

6.  P53 Overexpression as an Indicator of Overall Survival and Response to Treatment in Osteosarcomas.

Authors:  Zsuzsa Pápai; Christina N Féja; Eid N Hanna; Mariann Sztán; Edit Oláh; Miklós Szendrôi
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

7.  Allelic Losses from Chromosome 17 in Human Osteosarcomas.

Authors:  Marianna Sztán; Zsuzsa Pápai; Miklós Szendrôi; Marco van der Looij; Edith Oláh
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

8.  Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.

Authors:  Jørn Henriksen; Trude H Aagesen; Gunhild M Maelandsmo; Ragnhild A Lothe; Ola Myklebost; Anne Forus
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

9.  Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors.

Authors:  M Giovannini; L Selleri; J A Biegel; K Scotlandi; B S Emanuel; G A Evans
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  3 in total

1.  Clarifying prognostic factors of small cell osteosarcoma: A pooled analysis of 20 cases and the literature.

Authors:  Jingyu Zhong; Yangfan Hu; Liping Si; Jia Geng; Yue Xing; Qiong Jiao; Huizhen Zhang; Weiwu Yao
Journal:  J Bone Oncol       Date:  2020-07-15       Impact factor: 4.072

2.  Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.

Authors:  Carl R Walkley; Rameez Qudsi; Vijay G Sankaran; Jennifer A Perry; Monica Gostissa; Sanford I Roth; Stephen J Rodda; Erin Snay; Patricia Dunning; Frederic H Fahey; Frederick W Alt; Andrew P McMahon; Stuart H Orkin
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

3.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.